Home Cart Sign in  
Chemical Structure| 1784252-84-1 Chemical Structure| 1784252-84-1

Structure of C-021 2HCl
CAS No.: 1784252-84-1

Chemical Structure| 1784252-84-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

C 021 2HCl is a potent CCR4 chemokine receptor antagonist.

Synonyms: C-021 dihydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of C-021 2HCl

CAS No. :1784252-84-1
Formula : C27H43Cl2N5O2
M.W : 540.57
SMILES Code : COC1=CC2=NC(N3CCC(N4CCCCC4)CC3)=NC(NC5CCCCCC5)=C2C=C1OC.[H]Cl.[H]Cl
Synonyms :
C-021 dihydrochloride
MDL No. :MFCD16618393
InChI Key :GKJKNYQUFAPLOQ-UHFFFAOYSA-N
Pubchem ID :56972238

Safety of C-021 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of C-021 2HCl

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
sensory neurons 1 μM CCL22 was able to directly activate neurons and enhance their excitability after injury. These responses were blocked using C 021 and small interfering RNA (siRNA)-targeting CCR4. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2118238119

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male albino Swiss mice Chronic constriction injury (CCI) of the sciatic nerve Intraperitoneal (i.p.) or intrathecal (i.t.) injection 1, 5, 10, or 20 mg/kg (i.p.); 10, 20, or 30 µg/5µl (i.t.) Single administration, behavioral tests conducted at 1, 4, and 24h post-administration To evaluate the effect of C021 on CCI-induced tactile and thermal hypersensitivity. Results showed that C021 dose-dependently diminished neuropathic pain-related behaviors in CCI-exposed mice. Front Immunol. 2020 Jul 14;11:1241
C57Bl/6 mice Acute liver failure model Intraperitoneal injection 1 mg/kg Once daily for 3 days To evaluate the neuroprotective effects of C021 on hepatic encephalopathy induced by acute liver failure. Results showed that pretreatment with C021 significantly improved neurological outcomes in AOM-treated mice, reduced microglia activation, decreased phosphorylation of ERK1/2, and alleviated AOM-induced cytokine upregulation. J Neuroinflammation. 2014 Jul 10;11:121
Mice Postoperative pain model Intraplantar injection 2 mM Single injection, observed for 6 hours Blocking the interaction of CCL17 and CCL22 with CCR4 significantly reduced mechanical hypersensitivity, indicating that the mechanical response depends on the interaction of these chemokines with their receptor CCR4. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2118238119
Mice HCC model Intraperitoneal injection 10 μmol kg−1 Every 3 days To evaluate the inhibitory effect of C-021 on SOX12-mediated HCC metastasis Adv Sci (Weinh). 2024 Sep;11(36):e2310304

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.85mL

0.37mL

0.18mL

9.25mL

1.85mL

0.92mL

18.50mL

3.70mL

1.85mL

References

 

Historical Records

Categories